Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-843
Closed -$210K 210
2021
Q1
$210K Buy
+843
New +$201K 0.12% 178
2020
Q4
Sell
-1,248
Closed -$317K 466
2020
Q3
$317K Buy
1,248
+161
+15% +$39.9K 0.17% 134
2020
Q2
$256K Sell
1,087
-1,956
-64% -$446K 0.14% 128
2020
Q1
$617K Buy
3,043
+111
+4% +$24.2K 0.36% 72
2019
Q4
$654K Buy
2,932
+1,709
+140% +$377K 0.33% 75
2019
Q3
$237K Sell
1,223
-199
-14% -$38.2K 0.21% 144
2019
Q2
$255K Buy
1,422
+120
+9% +$21.5K 0.27% 116
2019
Q1
$247K Sell
1,302
-659
-34% -$126K 0.32% 98
2018
Q4
$382K Buy
+1,961
New +$383K 0.2% 114

Other funds holding AMGN

Hayden Royal's AMGN Position: Q2 2021 in Review

Hayden Royal sold out of Amgen (AMGN) in Q2 2021, closing a stake of 843 shares — an estimated $210K sold.

Hayden Royal first reported a position in AMGN in Q4 2018 and held it in 9 quarters. The position peaked at $654K in Q4 2019. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Hayden Royal reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Hayden Royal sold 843 Amgen shares in Q2 2021, an estimated $210K.
  • Hayden Royal first reported a position in Amgen in Q4 2018 and held it in 9 quarters.
  • Hayden Royal's Amgen position peaked at $654K in Q4 2019.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Hayden Royal's 13F filing for Q2 2021, filed 11 Aug 2021.